Literature DB >> 34297882

Associations between alcohol consumption and hepatic steatosis in the USA.

Sebastian Niezen1, Hirsh D Trivedi1, Kenneth J Mukamal1, Zhenghui G Jiang1.   

Abstract

Despite being widely recognized as a common cause of fatty liver, the exact impact of alcohol consumption on hepatic steatosis in the general population is elusive. The recent National Health and Nutrition Examination Survey (NHANES) allowed us to examine this relationship among US adults. Herein, we extracted data on detailed alcohol consumption and controlled attenuation parameter (CAP) by FibroScan from 4509 participants in NHANES 2017-2018. Compared to metabolic risk factors such as diabetes and obesity, the association between alcohol consumption and CAP was less significant. In multivariable analysis, only those drinking 5-7 times per week showed significant increases in CAP scores. Although both frequency and quantity of drinking were positively associated with CAP score, only frequency remained significant after adjustment for quantity and binge drinking. These epidemiological observations suggested that the impact of alcohol on hepatic steatosis was much smaller than metabolic factors and dependent upon the frequency of drinking.
© 2021 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  CAP; FibroScan; alcoholic liver disease; hepatic steatosis

Mesh:

Year:  2021        PMID: 34297882      PMCID: PMC9330542          DOI: 10.1111/liv.15020

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   8.754


  8 in total

1.  Roles of alcohol consumption in fatty liver: a longitudinal study.

Authors:  Akio Moriya; Yoshiaki Iwasaki; Souhei Ohguchi; Eizo Kayashima; Tadahiko Mitsumune; Hideaki Taniguchi; Masaharu Ando; Kazuhide Yamamoto
Journal:  J Hepatol       Date:  2014-11-27       Impact factor: 25.083

2.  Risks of Light and Moderate Alcohol Use in Fatty Liver Disease: Follow-Up of Population Cohorts.

Authors:  Fredrik Åberg; Pauli Puukka; Veikko Salomaa; Satu Männistö; Annamari Lundqvist; Liisa Valsta; Markus Perola; Martti Färkkilä; Antti Jula
Journal:  Hepatology       Date:  2019-10-08       Impact factor: 17.425

Review 3.  Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis.

Authors:  Charles S Lieber
Journal:  Alcohol       Date:  2004-08       Impact factor: 2.405

4.  Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases.

Authors:  David W Crabb; Gene Y Im; Gyongyi Szabo; Jessica L Mellinger; Michael R Lucey
Journal:  Hepatology       Date:  2020-01       Impact factor: 17.425

5.  Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men.

Authors:  Kenneth J Mukamal; Katherine M Conigrave; Murray A Mittleman; Carlos A Camargo; Meir J Stampfer; Walter C Willett; Eric B Rimm
Journal:  N Engl J Med       Date:  2003-01-09       Impact factor: 91.245

6.  Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease.

Authors:  Michelle T Long; Joseph M Massaro; Udo Hoffmann; Emelia J Benjamin; Timothy S Naimi
Journal:  Clin Gastroenterol Hepatol       Date:  2019-11-14       Impact factor: 11.382

7.  Transient Elastography-Assessed Hepatic Steatosis and Fibrosis Are Associated With Body Composition in the United States.

Authors:  Aynur Unalp-Arida; Constance E Ruhl
Journal:  Clin Gastroenterol Hepatol       Date:  2021-02-05       Impact factor: 11.382

8.  Molecular mechanism of alcoholic fatty liver.

Authors:  Karuna Rasineni; Carol A Casey
Journal:  Indian J Pharmacol       Date:  2012-05       Impact factor: 1.200

  8 in total
  1 in total

1.  The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database.

Authors:  Naim Alkhouri; Ashraf Almomani; Phuc Le; Julia Y Payne; Imad Asaad; Celine Sakkal; Miriam Vos; Mazen Noureddin; Prabhat Kumar
Journal:  BMC Gastroenterol       Date:  2022-07-30       Impact factor: 2.847

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.